Fagron NV operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fagron NV with three other
pharmaceutical manufacturers in Europe:
Dechra Pharmaceuticals PLC
of UNITED KINGDOM
sales of £481.80 million [US$589.72 million]
of which 63%
was European Pharmaceuticals),
(557.12 million Euros [US$611.55 million]
based in GERMANY
(446.44 million Euros [US$490.05 million]
of which 76%
was EVT Execute).
During the year ended December of 2019, sales at
Fagron NV were 534.70 million Euro (US$586.93 million).
increase of 13.4%
versus 2018, when the company's sales were 471.68 million Euro.
This was the third consecutive year of growth at Fagron NV.